Trials / Active Not Recruiting
Active Not RecruitingNCT06043700
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No treatment intervention will be administered. |
Timeline
- Start date
- 2023-09-12
- Primary completion
- 2028-03-31
- Completion
- 2028-03-31
- First posted
- 2023-09-21
- Last updated
- 2026-03-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06043700. Inclusion in this directory is not an endorsement.